Personalized Medicine for Cancer Market, Global Outlook and Forecast 2022-2028

June 2022 | 60 pages | ID: P98A8EF5D0A0EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Personalized Medicine for Cancer in Global, including the following market information:

Global Personalized Medicine for Cancer Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Personalized Medicine for Cancer market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Immunotherapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Personalized Medicine for Cancer include Bayer, GlaxoSmithKline, Novartis, Sanofi, Pfizer, Amgen, Merck, Bristol-Myers Squibb and Ariad Pharmaceuticals (Takeda), etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Personalized Medicine for Cancer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Personalized Medicine for Cancer Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Personalized Medicine for Cancer Market Segment Percentages, by Type, 2021 (%)

• Immunotherapy
• Targeted Therapy
• Chemotherapy
• Hormone Therapy
• Others

Global Personalized Medicine for Cancer Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Personalized Medicine for Cancer Market Segment Percentages, by Application, 2021 (%)

• Breast Cancer
• Blood Cancer
• Gastrointestinal Cancer
• Prostate Cancer
• Skin Cancer
• Lung Cancer
• Others

Global Personalized Medicine for Cancer Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Personalized Medicine for Cancer Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Personalized Medicine for Cancer revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Personalized Medicine for Cancer revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Bayer
• GlaxoSmithKline
• Novartis
• Sanofi
• Pfizer
• Amgen
• Merck
• Bristol-Myers Squibb
• Ariad Pharmaceuticals (Takeda)
• Eli Lilly
• Roche
• Boehringer Ingelheim
• Johnson and Johnson
• Teva Pharmaceuticals

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Personalized Medicine for Cancer Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Personalized Medicine for Cancer Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PERSONALIZED MEDICINE FOR CANCER OVERALL MARKET SIZE

2.1 Global Personalized Medicine for Cancer Market Size: 2021 VS 2028
2.2 Global Personalized Medicine for Cancer Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Personalized Medicine for Cancer Players in Global Market
3.2 Top Global Personalized Medicine for Cancer Companies Ranked by Revenue
3.3 Global Personalized Medicine for Cancer Revenue by Companies
3.4 Top 3 and Top 5 Personalized Medicine for Cancer Companies in Global Market, by Revenue in 2021
3.5 Global Companies Personalized Medicine for Cancer Product Type
3.6 Tier 1, Tier 2 and Tier 3 Personalized Medicine for Cancer Players in Global Market
  3.6.1 List of Global Tier 1 Personalized Medicine for Cancer Companies
  3.6.2 List of Global Tier 2 and Tier 3 Personalized Medicine for Cancer Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Personalized Medicine for Cancer Market Size Markets, 2021 & 2028
  4.1.2 Immunotherapy
  4.1.3 Targeted Therapy
  4.1.4 Chemotherapy
  4.1.5 Hormone Therapy
  4.1.6 Others
4.2 By Type - Global Personalized Medicine for Cancer Revenue & Forecasts
  4.2.1 By Type - Global Personalized Medicine for Cancer Revenue, 2017-2022
  4.2.2 By Type - Global Personalized Medicine for Cancer Revenue, 2023-2028
  4.2.3 By Type - Global Personalized Medicine for Cancer Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Personalized Medicine for Cancer Market Size, 2021 & 2028
  5.1.2 Breast Cancer
  5.1.3 Blood Cancer
  5.1.4 Gastrointestinal Cancer
  5.1.5 Prostate Cancer
  5.1.6 Skin Cancer
  5.1.7 Lung Cancer
  5.1.8 Others
5.2 By Application - Global Personalized Medicine for Cancer Revenue & Forecasts
  5.2.1 By Application - Global Personalized Medicine for Cancer Revenue, 2017-2022
  5.2.2 By Application - Global Personalized Medicine for Cancer Revenue, 2023-2028
  5.2.3 By Application - Global Personalized Medicine for Cancer Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Personalized Medicine for Cancer Market Size, 2021 & 2028
6.2 By Region - Global Personalized Medicine for Cancer Revenue & Forecasts
  6.2.1 By Region - Global Personalized Medicine for Cancer Revenue, 2017-2022
  6.2.2 By Region - Global Personalized Medicine for Cancer Revenue, 2023-2028
  6.2.3 By Region - Global Personalized Medicine for Cancer Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Personalized Medicine for Cancer Revenue, 2017-2028
  6.3.2 US Personalized Medicine for Cancer Market Size, 2017-2028
  6.3.3 Canada Personalized Medicine for Cancer Market Size, 2017-2028
  6.3.4 Mexico Personalized Medicine for Cancer Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Personalized Medicine for Cancer Revenue, 2017-2028
  6.4.2 Germany Personalized Medicine for Cancer Market Size, 2017-2028
  6.4.3 France Personalized Medicine for Cancer Market Size, 2017-2028
  6.4.4 U.K. Personalized Medicine for Cancer Market Size, 2017-2028
  6.4.5 Italy Personalized Medicine for Cancer Market Size, 2017-2028
  6.4.6 Russia Personalized Medicine for Cancer Market Size, 2017-2028
  6.4.7 Nordic Countries Personalized Medicine for Cancer Market Size, 2017-2028
  6.4.8 Benelux Personalized Medicine for Cancer Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Personalized Medicine for Cancer Revenue, 2017-2028
  6.5.2 China Personalized Medicine for Cancer Market Size, 2017-2028
  6.5.3 Japan Personalized Medicine for Cancer Market Size, 2017-2028
  6.5.4 South Korea Personalized Medicine for Cancer Market Size, 2017-2028
  6.5.5 Southeast Asia Personalized Medicine for Cancer Market Size, 2017-2028
  6.5.6 India Personalized Medicine for Cancer Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Personalized Medicine for Cancer Revenue, 2017-2028
  6.6.2 Brazil Personalized Medicine for Cancer Market Size, 2017-2028
  6.6.3 Argentina Personalized Medicine for Cancer Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Personalized Medicine for Cancer Revenue, 2017-2028
  6.7.2 Turkey Personalized Medicine for Cancer Market Size, 2017-2028
  6.7.3 Israel Personalized Medicine for Cancer Market Size, 2017-2028
  6.7.4 Saudi Arabia Personalized Medicine for Cancer Market Size, 2017-2028
  6.7.5 UAE Personalized Medicine for Cancer Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Bayer
  7.1.1 Bayer Corporate Summary
  7.1.2 Bayer Business Overview
  7.1.3 Bayer Personalized Medicine for Cancer Major Product Offerings
  7.1.4 Bayer Personalized Medicine for Cancer Revenue in Global Market (2017-2022)
  7.1.5 Bayer Key News
7.2 GlaxoSmithKline
  7.2.1 GlaxoSmithKline Corporate Summary
  7.2.2 GlaxoSmithKline Business Overview
  7.2.3 GlaxoSmithKline Personalized Medicine for Cancer Major Product Offerings
  7.2.4 GlaxoSmithKline Personalized Medicine for Cancer Revenue in Global Market (2017-2022)
  7.2.5 GlaxoSmithKline Key News
7.3 Novartis
  7.3.1 Novartis Corporate Summary
  7.3.2 Novartis Business Overview
  7.3.3 Novartis Personalized Medicine for Cancer Major Product Offerings
  7.3.4 Novartis Personalized Medicine for Cancer Revenue in Global Market (2017-2022)
  7.3.5 Novartis Key News
7.4 Sanofi
  7.4.1 Sanofi Corporate Summary
  7.4.2 Sanofi Business Overview
  7.4.3 Sanofi Personalized Medicine for Cancer Major Product Offerings
  7.4.4 Sanofi Personalized Medicine for Cancer Revenue in Global Market (2017-2022)
  7.4.5 Sanofi Key News
7.5 Pfizer
  7.5.1 Pfizer Corporate Summary
  7.5.2 Pfizer Business Overview
  7.5.3 Pfizer Personalized Medicine for Cancer Major Product Offerings
  7.5.4 Pfizer Personalized Medicine for Cancer Revenue in Global Market (2017-2022)
  7.5.5 Pfizer Key News
7.6 Amgen
  7.6.1 Amgen Corporate Summary
  7.6.2 Amgen Business Overview
  7.6.3 Amgen Personalized Medicine for Cancer Major Product Offerings
  7.6.4 Amgen Personalized Medicine for Cancer Revenue in Global Market (2017-2022)
  7.6.5 Amgen Key News
7.7 Merck
  7.7.1 Merck Corporate Summary
  7.7.2 Merck Business Overview
  7.7.3 Merck Personalized Medicine for Cancer Major Product Offerings
  7.7.4 Merck Personalized Medicine for Cancer Revenue in Global Market (2017-2022)
  7.7.5 Merck Key News
7.8 Bristol-Myers Squibb
  7.8.1 Bristol-Myers Squibb Corporate Summary
  7.8.2 Bristol-Myers Squibb Business Overview
  7.8.3 Bristol-Myers Squibb Personalized Medicine for Cancer Major Product Offerings
  7.8.4 Bristol-Myers Squibb Personalized Medicine for Cancer Revenue in Global Market (2017-2022)
  7.8.5 Bristol-Myers Squibb Key News
7.9 Ariad Pharmaceuticals (Takeda)
  7.9.1 Ariad Pharmaceuticals (Takeda) Corporate Summary
  7.9.2 Ariad Pharmaceuticals (Takeda) Business Overview
  7.9.3 Ariad Pharmaceuticals (Takeda) Personalized Medicine for Cancer Major Product Offerings
  7.9.4 Ariad Pharmaceuticals (Takeda) Personalized Medicine for Cancer Revenue in Global Market (2017-2022)
  7.9.5 Ariad Pharmaceuticals (Takeda) Key News
7.10 Eli Lilly
  7.10.1 Eli Lilly Corporate Summary
  7.10.2 Eli Lilly Business Overview
  7.10.3 Eli Lilly Personalized Medicine for Cancer Major Product Offerings
  7.10.4 Eli Lilly Personalized Medicine for Cancer Revenue in Global Market (2017-2022)
  7.10.5 Eli Lilly Key News
7.11 Roche
  7.11.1 Roche Corporate Summary
  7.11.2 Roche Business Overview
  7.11.3 Roche Personalized Medicine for Cancer Major Product Offerings
  7.11.4 Roche Personalized Medicine for Cancer Revenue in Global Market (2017-2022)
  7.11.5 Roche Key News
7.12 Boehringer Ingelheim
  7.12.1 Boehringer Ingelheim Corporate Summary
  7.12.2 Boehringer Ingelheim Business Overview
  7.12.3 Boehringer Ingelheim Personalized Medicine for Cancer Major Product Offerings
  7.12.4 Boehringer Ingelheim Personalized Medicine for Cancer Revenue in Global Market (2017-2022)
  7.12.5 Boehringer Ingelheim Key News
7.13 Johnson and Johnson
  7.13.1 Johnson and Johnson Corporate Summary
  7.13.2 Johnson and Johnson Business Overview
  7.13.3 Johnson and Johnson Personalized Medicine for Cancer Major Product Offerings
  7.13.4 Johnson and Johnson Personalized Medicine for Cancer Revenue in Global Market (2017-2022)
  7.13.5 Johnson and Johnson Key News
7.14 Teva Pharmaceuticals
  7.14.1 Teva Pharmaceuticals Corporate Summary
  7.14.2 Teva Pharmaceuticals Business Overview
  7.14.3 Teva Pharmaceuticals Personalized Medicine for Cancer Major Product Offerings
  7.14.4 Teva Pharmaceuticals Personalized Medicine for Cancer Revenue in Global Market (2017-2022)
  7.14.5 Teva Pharmaceuticals Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Personalized Medicine for Cancer Market Opportunities & Trends in Global Market
Table 2. Personalized Medicine for Cancer Market Drivers in Global Market
Table 3. Personalized Medicine for Cancer Market Restraints in Global Market
Table 4. Key Players of Personalized Medicine for Cancer in Global Market
Table 5. Top Personalized Medicine for Cancer Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Personalized Medicine for Cancer Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Personalized Medicine for Cancer Revenue Share by Companies, 2017-2022
Table 8. Global Companies Personalized Medicine for Cancer Product Type
Table 9. List of Global Tier 1 Personalized Medicine for Cancer Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Personalized Medicine for Cancer Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Personalized Medicine for Cancer Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Personalized Medicine for Cancer Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Personalized Medicine for Cancer Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Personalized Medicine for Cancer Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Personalized Medicine for Cancer Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Personalized Medicine for Cancer Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Personalized Medicine for Cancer Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Personalized Medicine for Cancer Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Personalized Medicine for Cancer Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Personalized Medicine for Cancer Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Personalized Medicine for Cancer Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Personalized Medicine for Cancer Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Personalized Medicine for Cancer Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Personalized Medicine for Cancer Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Personalized Medicine for Cancer Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Personalized Medicine for Cancer Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Personalized Medicine for Cancer Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Personalized Medicine for Cancer Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Personalized Medicine for Cancer Revenue, (US$, Mn), 2023-2028
Table 30. Bayer Corporate Summary
Table 31. Bayer Personalized Medicine for Cancer Product Offerings
Table 32. Bayer Personalized Medicine for Cancer Revenue (US$, Mn), (2017-2022)
Table 33. GlaxoSmithKline Corporate Summary
Table 34. GlaxoSmithKline Personalized Medicine for Cancer Product Offerings
Table 35. GlaxoSmithKline Personalized Medicine for Cancer Revenue (US$, Mn), (2017-2022)
Table 36. Novartis Corporate Summary
Table 37. Novartis Personalized Medicine for Cancer Product Offerings
Table 38. Novartis Personalized Medicine for Cancer Revenue (US$, Mn), (2017-2022)
Table 39. Sanofi Corporate Summary
Table 40. Sanofi Personalized Medicine for Cancer Product Offerings
Table 41. Sanofi Personalized Medicine for Cancer Revenue (US$, Mn), (2017-2022)
Table 42. Pfizer Corporate Summary
Table 43. Pfizer Personalized Medicine for Cancer Product Offerings
Table 44. Pfizer Personalized Medicine for Cancer Revenue (US$, Mn), (2017-2022)
Table 45. Amgen Corporate Summary
Table 46. Amgen Personalized Medicine for Cancer Product Offerings
Table 47. Amgen Personalized Medicine for Cancer Revenue (US$, Mn), (2017-2022)
Table 48. Merck Corporate Summary
Table 49. Merck Personalized Medicine for Cancer Product Offerings
Table 50. Merck Personalized Medicine for Cancer Revenue (US$, Mn), (2017-2022)
Table 51. Bristol-Myers Squibb Corporate Summary
Table 52. Bristol-Myers Squibb Personalized Medicine for Cancer Product Offerings
Table 53. Bristol-Myers Squibb Personalized Medicine for Cancer Revenue (US$, Mn), (2017-2022)
Table 54. Ariad Pharmaceuticals (Takeda) Corporate Summary
Table 55. Ariad Pharmaceuticals (Takeda) Personalized Medicine for Cancer Product Offerings
Table 56. Ariad Pharmaceuticals (Takeda) Personalized Medicine for Cancer Revenue (US$, Mn), (2017-2022)
Table 57. Eli Lilly Corporate Summary
Table 58. Eli Lilly Personalized Medicine for Cancer Product Offerings
Table 59. Eli Lilly Personalized Medicine for Cancer Revenue (US$, Mn), (2017-2022)
Table 60. Roche Corporate Summary
Table 61. Roche Personalized Medicine for Cancer Product Offerings
Table 62. Roche Personalized Medicine for Cancer Revenue (US$, Mn), (2017-2022)
Table 63. Boehringer Ingelheim Corporate Summary
Table 64. Boehringer Ingelheim Personalized Medicine for Cancer Product Offerings
Table 65. Boehringer Ingelheim Personalized Medicine for Cancer Revenue (US$, Mn), (2017-2022)
Table 66. Johnson and Johnson Corporate Summary
Table 67. Johnson and Johnson Personalized Medicine for Cancer Product Offerings
Table 68. Johnson and Johnson Personalized Medicine for Cancer Revenue (US$, Mn), (2017-2022)
Table 69. Teva Pharmaceuticals Corporate Summary
Table 70. Teva Pharmaceuticals Personalized Medicine for Cancer Product Offerings
Table 71. Teva Pharmaceuticals Personalized Medicine for Cancer Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Personalized Medicine for Cancer Segment by Type in 2021
Figure 2. Personalized Medicine for Cancer Segment by Application in 2021
Figure 3. Global Personalized Medicine for Cancer Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Personalized Medicine for Cancer Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Personalized Medicine for Cancer Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Personalized Medicine for Cancer Revenue in 2021
Figure 8. By Type - Global Personalized Medicine for Cancer Revenue Market Share, 2017-2028
Figure 9. By Application - Global Personalized Medicine for Cancer Revenue Market Share, 2017-2028
Figure 10. By Region - Global Personalized Medicine for Cancer Revenue Market Share, 2017-2028
Figure 11. By Country - North America Personalized Medicine for Cancer Revenue Market Share, 2017-2028
Figure 12. US Personalized Medicine for Cancer Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Personalized Medicine for Cancer Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Personalized Medicine for Cancer Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Personalized Medicine for Cancer Revenue Market Share, 2017-2028
Figure 16. Germany Personalized Medicine for Cancer Revenue, (US$, Mn), 2017-2028
Figure 17. France Personalized Medicine for Cancer Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Personalized Medicine for Cancer Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Personalized Medicine for Cancer Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Personalized Medicine for Cancer Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Personalized Medicine for Cancer Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Personalized Medicine for Cancer Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Personalized Medicine for Cancer Revenue Market Share, 2017-2028
Figure 24. China Personalized Medicine for Cancer Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Personalized Medicine for Cancer Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Personalized Medicine for Cancer Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Personalized Medicine for Cancer Revenue, (US$, Mn), 2017-2028
Figure 28. India Personalized Medicine for Cancer Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Personalized Medicine for Cancer Revenue Market Share, 2017-2028
Figure 30. Brazil Personalized Medicine for Cancer Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Personalized Medicine for Cancer Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Personalized Medicine for Cancer Revenue Market Share, 2017-2028
Figure 33. Turkey Personalized Medicine for Cancer Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Personalized Medicine for Cancer Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Personalized Medicine for Cancer Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Personalized Medicine for Cancer Revenue, (US$, Mn), 2017-2028
Figure 37. Bayer Personalized Medicine for Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. GlaxoSmithKline Personalized Medicine for Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis Personalized Medicine for Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Sanofi Personalized Medicine for Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Pfizer Personalized Medicine for Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Amgen Personalized Medicine for Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Merck Personalized Medicine for Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Bristol-Myers Squibb Personalized Medicine for Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Ariad Pharmaceuticals (Takeda) Personalized Medicine for Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Eli Lilly Personalized Medicine for Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Roche Personalized Medicine for Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Boehringer Ingelheim Personalized Medicine for Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Johnson and Johnson Personalized Medicine for Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Teva Pharmaceuticals Personalized Medicine for Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)